Business ❯ Corporate Governance ❯ Investor Relations
Securities Fraud Class Action Participation Legal Actions Legal Representation Class Action Lawsuits Litigation Lead Plaintiff Appointments Legal Claims Loss Recovery Legal Compliance Legal Recourse Securities Class Actions Lead Plaintiff Litigation Support Legal Notices Misleading Statements Class Action Claims Class Action Representation Securities Litigation Dividends Fraudulent Practices Investor Compensation Securities Claims Petroleum Investments Financial Disclosures Legal Rights of Investors Compensation Claims Voting Rights CEO Responsibilities Legal Action Legal Obligations
The case centers on October 2025 disclosures of slower adoption of two electrophysiology devices, followed by a 32% share drop.